Q fever vaccination of children in Australia: Limited experience to date
Related Experiment Video
Updated: Jan 31, 2026

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Mark Armstrong1, Josh Francis2, Jenny Robson3
1Infectious Diseases Unit, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
Insights
The Q fever vaccine, licensed for adults, shows promise for children. Vaccination was feasible and safe in pediatric cases, suggesting its potential for protecting children at high risk of Coxiella burnetii infection.
Area of Science:
- Infectious Diseases
- Vaccinology
- Pediatrics
Background:
- Q fever, caused by Coxiella burnetii, presents significant health risks.
- The only registered Q fever vaccine is not licensed for individuals under 15 due to limited pediatric data.
- Australia has unique experience with Q fever vaccination in children.
Purpose of the Study:
- To review the safety and feasibility of Q fever vaccination in children under 15 in Australia.
- To assess adverse effects and outcomes of pediatric Q fever vaccination.
- To inform future vaccination strategies for children at risk of Q fever.
Main Methods:
- Retrospective review of medical records for children (<15 years) who received the Q fever vaccine.
- Data collection included risk factors, vaccination procedures, dosage, and adverse events.
- Informed consent was obtained from guardians for data abstraction.
Main Results:
- Twelve pediatric cases of Q fever vaccination were identified.
- Vaccination was feasible, with weight-based dosing adjustments for younger children.
- No significant adverse effects were reported following vaccination.
Conclusions:
- Q fever vaccination appears safe and feasible in children.
- Consideration of the vaccine is warranted for pediatric cases at high risk of infection.
- Further prospective studies and expanded registries are needed to confirm efficacy and safety in all age groups.
Aim:
Q fever is a zoonotic disease caused by the bacterium Coxiella burnetii and is associated with significant morbidity and mortality in both adults and children. Australia is the only country that has produced and registered a Q fever vaccine for human use, but this vaccine is licenced only for people aged over 15 years as data and experience in children are limited. This review describes the experience of Q fever vaccination of known paediatric cases in Australia to date.
Methods:
Patients aged younger than 15 years who received the Q fever vaccination had data abstracted from medical records after consent was obtained from the relevant guardians. Data on risk factors for Q fever, skin testing procedure, dose of vaccination, adverse effects and follow-up assessment were obtained.
Results:
Twelve children were identified as having received the Q fever vaccination. Vaccination was feasible, with empirical weight-based dose adjustment performed for younger children. There were no significant adverse effects.
Conclusions:
Q fever vaccine may be safe in children and should be considered in children who are at significant risk of Q fever infection. Safe vaccine protocols with proven efficacy will allow children of all ages to be protected. Prospective studies of vaccination in children are indicated. Expanding available Q fever registries to include children would allow outcomes to be systematically followed.
More Related Videos
09:13Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
06:22Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
Published on: February 10, 2023
Related Concept Videos
Vaccinations
Types of Fever
Here are the different types of fever:
Patterns of Fever
Limiting Reactant
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
The Number e as a Limit